Autologous blood injection for tendinopathy (IPG438)
Fast, easy summary view of NICE guidance on 'musculoskeletal conditions'
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Autologous blood injection for tendinopathy.
This document replaces previous guidance on Autologus blood injection (interventional procedure guidance IPG 279).
Tendons are bands of fibrous connective tissue that connect muscle to bone. ‘Tendinopathy’ describes a range of conditions that affect tendons, usually caused by overuse. The most common tendons affected are in the elbow, the heel and the knee. Symptoms include pain, weakness and stiffness. In autologous blood injection, blood is taken from the patient and re-injected around the affected tendon. Sometimes the blood is separated into red blood cells and platelets (cell fragments that produce substances called growth factors) before injecting the sample containing mostly platelets. The aim is to supply the tendon with growth factors that start the healing process.
T74.6 Autologous blood injection into tendon
Chapter ‘Z’ site code to identify tendon
Y53.2 Approach to organ under ultrasonic control is assigned following T74.6 when performed under ultrasonic guidance.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG438 Autologous blood injection for tendinopathy: guidance (web format)
- Autologous blood injection for refractory tendonitis: overview
- Autologous blood injection for refractory tendonitis: consultation document
- IPG438 Autologous blood injection for tendinopathy: consultation comments
- IPG438 Autologous blood injection for tendinopathy: equality impact assessment
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: musculoskeletal conditions
This page was last updated: 27 February 2014
- Web format
- Full Guidance (PDF)
- IPG438 Trin tendinopathi drwy chwistrellu gwaed y claf ei hun i mewn i ardal boenus y tendon ac o'i amgylch: Gwybodaeth i'r cyhoedd (fformat MS Word)
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.